Study guide
4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances
Medical Council of Canada Qualifying Examination Part I MCCQE Part I
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Blueprint & Canadian Medical Practice
1.1 MCCQE Part I Format, Scoring (439 Scale), & Strategy 1.2 The MCC Blueprint Matrix: Dimensions of Care & Physician Activities 1.3 Canadian Healthcare System, CanMEDS Roles, & Interprofessional Care 1.4 Evidence-Based Medicine, Study Design, & Clinical Statistics
2 Chapter 2: Population Health, Health Promotion & Preventive Care
2.1 Canadian Task Force on Preventive Health Care (CTFPHC) Screening Guidelines 2.2 Immunization Schedules (NACI) & Vaccine-Preventable Diseases across Lifespan 2.3 Disease Prevention, Lifestyle Counselling, & Harm Reduction 2.4 Outbreak Management, Disease Surveillance, & Infection Control 2.5 Occupational, Environmental, & Travel Medicine in Canada
3 Chapter 3: Internal Medicine — Cardiovascular & Respiratory Systems
3.1 Hypertension Canada 2020/2025 Guidelines, Dyslipidemia, & Primary Prevention 3.2 Ischemic Heart Disease, Acute Coronary Syndromes, & Heart Failure Management 3.3 Arrhythmias, Valvular Heart Disease, & Infective Endocarditis 3.4 Asthma, COPD, & Respiratory Failure (CTS Guidelines) 3.5 Thromboembolic Disease (DVT/PE), Pneumonia, & Pleural Effusions
4 Chapter 4: Internal Medicine — GI, Endocrine, Renal & Hematology/Oncology
4.1 Gastrointestinal Disorders, Acute Abdomen, & Liver/Biliary Disease 4.2 Diabetes Canada 2020/2025 Guidelines & Glycemic Management 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances 4.4 Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), & Nephrology 4.5 Hematology, Anemia Evaluation, Transfusion Medicine, & Common Cancers
5 Chapter 5: General Surgery, Orthopedics, & Emergency Care
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications 5.2 Trauma Management (ATLS Protocol) & Burns 5.3 Acute Surgical Conditions (Appendicitis, Cholecystitis, Bowel Obstruction) 5.4 Fractures, Dislocations, Joint Pain, & Musculoskeletal Emergencies 5.5 Vascular Emergencies, Wound Care, & Shock Recognition
6 Chapter 6: Pediatrics & Adolescent Health
6.1 Pediatric Growth, Developmental Milestones, & Well-Child Examinations 6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies 6.3 Pediatric Respiratory Emergencies (Croup, Bronchiolitis, Asthma) 6.4 Common Pediatric Infections, Exanthems, & Fever of Unknown Origin 6.5 Pediatric Abdominal Pain, Dehydration, & Fluid Management
7 Chapter 7: Obstetrics & Gynecology
7.1 Routine Antepartum Care, Screening, & Prenatal Diagnosis (SOGC Guidelines) 7.2 Medical Complications of Pregnancy (Preeclampsia, Gestational Diabetes, Infections) 7.3 Labor, Intrapartum Management, & Postpartum Complications/Hemorrhage 7.4 Abnormal Uterine Bleeding, Gynecologic Infections, & Contraception/Menopause 7.5 Gynecologic Oncology & Pelvic Mass Evaluation
8 Chapter 8: Psychiatry & Mental Health
8.1 Mood Disorders (Depression, Bipolar) & Suicide Risk Assessment 8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders 8.3 Psychotic Disorders & Schizophrenia Management 8.4 Substance Use Disorders, Withdrawal Syndromes, & Harm Reduction 8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
9 Chapter 9: Neurology, Rheumatology, & Dermatology
9.1 Acute Stroke, TIA, & Neurovascular Emergencies 9.2 Headaches, Seizures, Movement Disorders, & Neuromuscular Disease 9.3 Inflammatory Arthritides (RA, Gout, SpA) & Systemic Autoimmune Diseases (SLE, Vasculitis) 9.4 Common Dermatologic Conditions, Cutaneous Manifestations of Systemic Disease, & Skin Cancers 9.5 Musculoskeletal Soft Tissue Injuries, Back Pain, & Physical Medicine
10 Chapter 10: Legal, Ethical, & Professional Behaviours in Canadian Practice
10.1 Informed Consent, Capacity Assessment, & Substitute Decision-Making (CMPA) 10.2 Medical Confidentiality, Privacy Laws (PIPEDA/PHIPA), & Disclosure of Harm 10.3 CMA Code of Ethics, Professionalism, & Physician Health/Boundary Issues 10.4 Mandatory Reporting (Child/Elder Abuse, Driving Safety, Fitness to Practice) & Quality/Safety
4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances
Key Takeaways Explain This Topic AI
Primary thyroid disorders are diagnosed via TSH and Free T4; subclinical hypothyroidism warrants treatment when TSH > 10 mIU/L or during pregnancy.
Thyroid Storm requires a strict therapeutic sequence: 1) Beta-blocker (propranolol), 2) Thionamide (PTU/methimazole), 3) Iodine solution (Lugol's at least 1h AFTER thionamides), and 4) IV Hydrocortisone.
Acute Adrenal Crisis presents with unexplained refractory shock, hyponatremia, and hyperkalemia; immediate treatment with IV Hydrocortisone 100 mg and IV Saline must NOT be delayed for diagnostic testing.
Hyponatremia evaluation requires systematic assessment of serum osmolality, urine osmolality, and volume status; SIADH is characterized by hypotonic euvolemic hyponatremia with UOsm > 100 mOsm/kg and UNa > 30 mmol/L.
Correction of chronic hyponatremia must not exceed 8–10 mmol/L in 24 hours to prevent irreversible Osmotic Demyelination Syndrome (ODS).
Last updated: July 2026
- 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances
- Thyroid Disorders & Emergency Management
- Diagnostic Interpretation Matrix
Condition Serum TSH Free T4 Level Primary Clinical Etiologies & Management
Primary Hypothyroidism Elevated (> 4.0 mIU/L) Low (< 10 pmol/L) Hashimoto Thyroiditis (anti-TPO positive); Treat with Levothyroxine (1.6 µg/kg/day)
Subclinical Hypothyroidism Elevated (> 4.0 mIU/L) Normal (10–25 pmol/L) Treat if TSH > 10 mIU/L, pregnant, symptomatic, or positive anti-TPO antibodies
Primary Hyperthyroidism Suppressed (< 0.4 mIU/L) Elevated (> 25 pmol/L) Graves Disease (anti-TSHR / TRAb positive), Toxic Multinodular Goiter; Methimazole/RAI
Subacute (De Quervain) Thyroiditis Suppressed (early phase) Elevated (early phase) Post-viral painful tender goiter, high ESR/CRP, low radioiodine uptake; NSAIDs/Prednisone
Central Hypothyroidism Low or Normal Low (< 10 pmol/L) Pituitary or hypothalamic pathology; Check adrenal axis BEFORE initiating Levothyroxine
Thyroid Storm (Thyrotoxic Crisis)
A life-threatening hypermetabolic state triggered by infection, surgery, trauma, or iodine load in uncontrolled hyperthyroidism. Diagnosed using the Burch-Wartofsky Point Scale (Score > 45) .
Clinical Features : High fever (>40°C), severe tachycardia / atrial fibrillation, agitation, delirium, jaundice, high-output heart failure.
Mandatory Treatment Sequence :
Beta-Blockers : Propranolol 60–80 mg PO q4h or IV (controls adrenergic hyperactivation and blocks peripheral T4-to-T3 conversion).
Thionamides : Propylthiouracil (PTU) 500–1000 mg loading dose then 250 mg PO q4h (blocks synthesis and peripheral conversion) OR Methimazole 20 mg PO q4h.
Iodine Solution : Lugol's solution 5 drops PO q8h or SSKI administered AT LEAST 1 HOUR AFTER thionamide administration (prevents organification of iodine into new hormone substrate - Jod-Basedow effect).
Corticosteroids : Hydrocortisone 100 mg IV q8h (inhibits peripheral T4-to-T3 conversion and treats relative adrenal exhaustion).
Myxedema Coma
Severe hypothyroid emergency presenting with the triad of hypothermia (<35°C) , hyponatremia , and altered mental status (lethargy/coma) , plus hypoventilation and bradycardia.
Treatment : Administer IV Levothyroxine (300–500 µg IV loading dose) combined with IV Hydrocortisone 100 mg q8h (hydrocortisone must be administered concurrently or prior to levothyroxine to prevent precipitating acute adrenal crisis).
- Adrenal Axis Disorders & Adrenal Crisis
- Primary vs Secondary Adrenal Insufficiency
Primary Adrenal Insufficiency (Addison's Disease) : Autoimmune destruction of adrenal cortex involving all three zones. Loss of BOTH cortisol and aldosterone. Features: Hyperpigmentation (high ACTH stimulates melanocytes), hyponatremia , hyperkalemia , non-anion gap metabolic acidosis, and postural hypotension. Diagnostics: Morning 8 AM cortisol (<80 nmol/L diagnostic; >500 nmol/L rules out) and Cosyntropin (ACTH) Stimulation Test (failure of cortisol to rise >500 nmol/L 30–60 min post 250 µg synthetic ACTH).
Secondary Adrenal Insufficiency : ACTH deficiency (e.g., abrupt withdrawal of chronic exogenous steroids). Aldosterone production via RAAS remains INTACT. Features: No hyperpigmentation, normal serum potassium , normal aldosterone.
Acute Adrenal Crisis
Emergency characterized by refractory hypovolemic shock, severe abdominal pain, high fever, hypoglycemia, hyponatremia, and hyperkalemia.
Emergency Management : Do NOT delay treatment for diagnostic testing! Administer immediate bolus of Hydrocortisone 100 mg IV , followed by 50–100 mg IV q6h, alongside rapid infusion of 0.9% Normal Saline with 5% Dextrose .
- Pituitary Pathology & Cushing's Syndrome Workup
- Pituitary Adenomas
Prolactinoma : Most common functional pituitary tumor. Microadenoma (<10 mm) vs Macroadenoma (≥10 mm causing bitemporal hemianopsia via optic chiasm compression). Symptoms: Galactorrhea, amenorrhea, hypogonadism, erectile dysfunction. Serum prolactin > 200 µg/L diagnostic. First-line therapy: Dopamine agonists ( Cabergoline or Bromocriptine).
Cushing's Syndrome Diagnostic Algorithmic Pathway
Step 1: Confirm Hypercortisolism (Requires 2 positive screening tests):
1 mg Overnight Dexamethasone Suppression Test (8 AM serum cortisol > 50 nmol/L is abnormal).
24-Hour Urinary Free Cortisol (> 3x ULN).
Late-Night Salivary Cortisol.
Step 2: Measure Plasma ACTH :
Low ACTH (< 2.0 pmol/L) : ACTH-Independent Cushing's (Adrenal adenoma/carcinoma, exogenous steroids). Perform Abdominal CT/MRI.
High ACTH (> 4.0 pmol/L) : ACTH-Dependent Cushing's. Proceed to High-Dose (8 mg) Dexamethasone Suppression Test or Pituitary MRI:
Cortisol Suppression > 50%: Cushing's Disease (Pituitary ACTH-secreting adenoma).
No Cortisol Suppression: Ectopic ACTH Secretion (Small cell lung carcinoma).
- Algorithmic Evaluation of Hyponatremia Step 1: Measured Serum Osmolality
- ├── > 295 mOsm/kg ──> Hypertonic Hyponatremia (Hyperglycemia, Mannitol)
- ├── 275-295 mOsm/kg ──> Isotonic / Pseudohyponatremia (Hypertriglyceridemia, Paraproteinemia)
- └── < 275 mOsm/kg ──> True Hypotonic Hyponatremia (Proceed to Step 2)
- Step 2: Urine Osmolality (UOsm)
- ├── < 100 mOsm/kg ──> Primary Polydipsia, Beer Potomania, Low-Solute Intake
- └── > 100 mOsm/kg ──> Impaired Renal Water Excretion (Proceed to Step 3)
- Step 3: Clinical Volume Status & Urine Sodium (UNa)
- ├── Hypovolemic
- │ ├── UNa < 20 mmol/L ──> Extra-renal loss (Vomiting, Diarrhea, Dehydration)
- │ └── UNa > 20 mmol/L ──> Renal loss (Diuretics, Mineralocorticoid deficiency)
- ├── Euvolemic (UNa > 30 mmol/L)
- │ └── SIADH, Hypothyroidism, Adrenal Insufficiency
- └── Hypervolemic
- ├── UNa < 20 mmol/L ──> Heart Failure, Cirrhosis, Nephrotic Syndrome
- └── UNa > 20 mmol/L ──> Acute or Chronic Renal Failure
- SIADH Diagnostic Criteria
Hypotonic euvolemic hyponatremia, UOsm > 100 mOsm/kg, UNa > 30 mmol/L, with normal thyroid, adrenal, and renal function. Etiologies: Small cell lung cancer, CNS disorders, SSRIs, Carbamazepine. Treatment: Fluid restriction (800–1000 mL/day), oral salt tablets, loop diuretics.
Correction Speed Limits & Osmotic Demyelination Syndrome (ODS)
Safety Limit : In chronic hyponatremia (>48h), serum sodium must be corrected by NO MORE THAN 8–10 mmol/L in 24 hours (and <18 mmol/L in 48 hours).
ODS Risk : Overly rapid correction causes brain demyelination, presenting days later with dysarthria, dysphagia, quadriparesis, and locked-in syndrome.
Severe Symptomatic Hyponatremia (Seizures/Coma): Administer 3% Hypertonic Saline 150 mL IV bolus over 20 minutes , repeated up to two times until symptoms resolve or serum Na increases by 4–6 mmol/L.
- Hyperkalemia & Calcium Emergencies
- Hyperkalemia Emergency Protocol (Serum K+ > 5.0 mmol/L)
ECG Sequence : Peaked T waves → PR prolongation → QRS widening → Sine wave pattern → V-Fib / Asystole.
Treatment Steps :
Membrane Stabilization : Calcium Gluconate 10% 10 mL IV over 2–5 min . Membrane protection acts within 1–3 minutes. Does NOT lower serum potassium!
Intracellular Shift : Regular Insulin 10 units IV + D50W 50 mL IV; Salbutamol 10–20 mg nebulized; Sodium Bicarbonate 50 mmol IV (if metabolic acidosis).
Potassium Elimination : Furosemide IV; Sodium Zirconium Cyclosilicate (SZC) PO; Emergency Hemodialysis.
Important
MCCQE1 Exam Trap: Iodine Timing in Thyroid Storm In Thyroid Storm, NEVER administer Iodine (Lugol's solution or SSKI) before starting Thionamides (PTU or Methimazole)! Giving iodine first provides substrate for thyroid peroxidase and accelerates thyroid hormone synthesis. Always wait AT LEAST 1 hour after thionamide administration before giving iodine.